Clinical trial Recruiting at 7 sites Observational Ages 18 to 89

Readiness for EXtubation (REXs) score for patients on invasive mechanical ventilation

Official title: A New Tool for Extubation Readiness in Mechanically Ventilated Patients: Readiness for EXtubation Score (REXs STUDY)

Run by Medipol University · NCT07098611 · Data updated 2026-11-12

This will test the Readiness for EXtubation (REXs) score to see if it can predict which ICU patients on invasive mechanical ventilation can be safely extubated.

Quick facts

Study typeObservational
Ages18 Years to 89 Years
SexAll
Enrollment470 (estimated)
SponsorMedipol University
Academic / other
Locations7 sites (Punta Arenas and 6 other locations)
StatusRecruiting
StartedJune 15, 2025
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedMay 5, 2026
Trial IDNCT07098611 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

ICU patients who are in the weaning process from invasive mechanical ventilation and meet readiness-for-extubation clinical criteria, excluding tracheostomized or pregnant patients, are ideal candidates.

Probably not a fit

Patients who are tracheostomized, pregnant, have diaphragmatic pacers, lack legal guardian consent, or are enrolled in other studies are not eligible and unlikely to benefit from this score.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational, multi-center study aims to develop and validate a multi-component Readiness for EXtubation (REXs) score using clinical parameters and spontaneous breathing trial results in patients undergoing weaning from invasive mechanical ventilation. The score will be derived and calibrated across participating ICUs, with extubation success defined as not requiring invasive mechanical support within 48 hours. Standard inclusion and exclusion criteria will be applied and sites will report findings following the STROBE guidance. Collected data will be used to test predictive performance and optimize score thresholds before broader validation.

Why it matters

Potential benefit: If successful, the REXs score could help clinicians reduce failed extubations and avoid unnecessary prolonged ventilation.

How similar studies have gone: Other multi-component weaning and extubation prediction scores and SBT-based approaches have been used with mixed success, so REXs builds on prior work but is not yet definitive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- Patients who are in the weaning process from mechanical ventilation after being connected to invasive mechanical ventilation in the intensive care unit.

Exclusion Criteria:

* Patients without legal guardian consent.
* Tracheostomized patients.
* Patients enrolled in other studies.
* Individuals with diaphragmatic pacers.
* Pregnant patients.

Where it's running

  • University of Magallanes
    Punta Arenas, Chile
    Recruiting
  • Cairo University
    Cairo, Egypt
    Recruiting
  • Shahid Beheshti University of Medical Sciences
    Tehran, Iran
    Recruiting
  • A.O.R.N. "Dei Colli" Monaldi Hospital
    Naples, Italy
    Recruiting
  • Monaldi-Cotugno Hospital
    Naples, Italy
    Recruiting
  • Hospital General Universitario Morales Meseguer
    Murcia, Spain
    Recruiting
Show 1 more location
  • İstanbul Medipol University
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.